EDP-938 clinical trials

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults with Acute Respiratory Syncytial Virus Infection who are at High Risk for Complications

This study is testing a new medicine, EDP-938, for adults with RSV who are well enough to be at home but are at higher risk of getting very sick. It aims to see if the medicine helps them recover faster from RSV symptoms like cough and breathlessness.